ArticleOPEN ACCESS

FIGARO-DKD adds new evidence to the cardiovascular benefits of finerenone across the spectrum of patients with type 2 diabetes and chronic kidney disease

European Heart Journal
DOI: 10.1093/eurheartj/ehab725
6Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Liuzzo, G., & Volpe, M. (2021, December 14). FIGARO-DKD adds new evidence to the cardiovascular benefits of finerenone across the spectrum of patients with type 2 diabetes and chronic kidney disease. European Heart Journal. Oxford University Press. https://doi.org/10.1093/eurheartj/ehab725

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free